Abstract. Introduction. RBMOnline - Vol 7. No Reproductive BioMedicine Online; on web 8 July 2003

Similar documents
Mishaps: How and Why Mistakes Occur in the Assisted Reproductive Technologies Laboratory, and How to Prevent Them

College of Physicians and Surgeons of Saskatchewan STANDARDS. Assisted Reproductive Technology PREAMBLE

Quality Control Processes Within the Embryology Laboratory. Klaus E. Wiemer, PhD Laboratory Director

Understanding eggs, sperm and embryos. Marta Jansa Perez Wolfson Fertility Centre

RAH s Regional Fertility & Women s Endocrine Clinic FAQs

CONSENT FOR ASSISTED REPRODUCTION In Vitro Fertilization, Intracytoplasmic Sperm Injection, Assisted Hatching, Embryo Freezing and Disposition

CRYOPRESERVATION OF SEMEN FROM TESTICULAR TISSUE

American Society for Reproductive Medicine, Birmingham, Alabama

Abstract. Introduction. Materials and methods. Patients and methods

POST - DOCTORAL FELLOWSHIP PROGRAMME IN REPRODUCTIVE MEDICINE. Anatomy : Male and Female genital tract

The Viability Of Human Embryos After Transport In A Dry Shipper Between Assisted Conception Laboratories

Analysis of factors affecting embryo implantation

Fertility 101. About SCRC. A Primary Care Approach to Diagnosing and Treating Infertility. Definition of Infertility. Dr.

Abstract. Introduction. RBMOnline - Vol 8. No Reproductive BioMedicine Online; on web 15 December 2003

Fertility treatment in trends and figures

INFERTILITY SERVICES

ASSISTED REPRODUCTIVE TECHNOLOGIES (ART)

A very warm welcome to the Herts & Essex Fertility Centre

Female Patient Name: Social Security # Male Patient Name: Social Security #

A very warm welcome to the Herts & Essex Fertility Centre

Preimplantation Genetic Testing (PGT) Fresh and Frozen Embryos Process, Risk, and Consent

Biology of fertility control. Higher Human Biology

FROM GAMETES TO BLASTOCYSTS. Simpler Processes, Less Stress, Better Results.

Cambridge IVF. Creating your future. Addenbrooke's Hospital Rosie Hospital

Adoption and Foster Care

Therapeutic Sperm Banking

(A) In-Vitro Fertilization (per cycle) HKD Payable to (1) Standard Drug Package (IVF) $11,000 CUHK. (5) Laboratory Fee for Embryo Transfer $1,800 CUHK

CONSENT FOR CRYOPRESERVATION OF EMBRYOS

SOUTHEND CENTRES FERTILITY CLINICS. FOR APPOINTMENTS CALL , DELHI

Financial Information for Patients Valid from 1 September Fertility Assessment and Consultations

STEPHEN R. LINCOLN, MD, FACOG Board Certified Reproductive Endocrinologist

Planning for Parenthood After a Cancer Diagnosis

We can give you the very best chance of having a baby.

Possibilities Plan. Access to the care you need.

Fertility Services Commissioning Policy

Myths About Success Rates Do they truly reflect quality of care

Pre-Implantation Genetic Diagnosis. Bradley Kalinsky, MD Amanda Kalinsky, RN, BSN

Welcome. Fertility treatment can be complicated. What s included. Your fertility treatment journey begins here. Fertility treatment basics 2

FERTILITY PRESERVATION. Juergen Eisermann, M.D., F.A.C.O.G South Florida Institute for Reproductive Medicine South Miami Florida

Commissioning Policy For In Vitro Fertilisation (IVF) / Intracytoplasmic Sperm Injection (ICSI) within Tertiary Infertility Services

NEW YORK STATE MODEL FOR REGULATORY OVERSIGHT OF ART AND GENETIC TESTING.

UNIVERSITY OF WASHINGTON MEDICAL CENTER Men s Health Center and Male Fertility Laboratory Sperm & Testis Cryopreservation Program Patient NAME and ID

Reproductive Technology, Genetic Testing, and Gene Therapy

1 - Advanced clinical course for ART with Hands on

NICE fertility guidelines. Hemlata Thackare MPhil MSc MRCOG Deputy Medical Director London Women s Clinic

Pre-Implantation Genetic Diagnosis. Bradley Kalinsky, MD Amanda Kalinsky, RN, BSN

European IVF Monitoring (EIM) Year: 2013

Consent for In Vitro Fertilization (IVF), Intracytoplasmic Sperm Injection (ICSI), and Embryo Cryopreservation/Disposition

Bringing Life to the Living

M Magdy EL-Sheikh FRCOG London, FRCS Glasgow Director ART unit Dr Soliman Fakeeh hospital Jeddah Saudi Arabia

Research Licence Renewal Inspection Report

Infertility treatment

Clinical Policy Committee

INDICATIONS OF IVF/ICSI

IVF & SURROGACY STANDARD OPTION PRICING LIV FERTILITY CENTER, PUERTO VALLARATA, MEXICO AUTUMN 2015

East and North Hertfordshire CCG. Fertility treatment and referral criteria for tertiary level assisted conception

MedStar Health, Inc. POLICY AND PROCEDURE MANUAL Policy Number: PA.018.MH Last Review Date: 08/04/2016 Effective Date: 01/01/2017

WELCOME TO NYU LANGONE FERTILITY CENTER

In this document, you will find information about donor screening and selection and all forms needed to reserve and purchase your eggs.

CONSENT TO CRYOPRESERVATION AND STORAGE OF HUMAN EMBRYOS

Fertility treatment and referral criteria for tertiary level assisted conception

Assisted Conception Policy

CRAFT HOSPITAL & RESEARCH CENTRE

FRESH OR FROZEN EMBYOS WHAT IS THE LATEST EVIDENCE? DR. ASMA MOMANI CLEVELAND CLINIC, ANDROLOGY LAB TRAINEE 2018

Fertility Services Commissioning Policy

Consent to Shipment of Frozen Embryos to and Short Term Storage of Frozen Embryos at the Family Fertility Center

Clinical Policy Committee

Fertility Preservation for Trans Women: Sperm Banking

Bumiputera Sarawak Bumiputera Sabah. Others Foreigner. Had previous natural pregnancy Previous IVF pregnancies. IVF live births.

IN VITRO FERTILISATION (IVF)

Number of oocytes and live births in IVF

WHAT IS A PATIENT CARE ADVOCATE?

Policy statement. Commissioning of Fertility treatments

Society for Assisted Reproductive Technology and American Society for Reproductive Medicine

Fertility treatment and referral criteria for tertiary level assisted conception

Andrology Services at HA Past, Present and Future. W.S.B. Yeung Department of Obstetrics and Gynaecology The University of Hong Kong

Reproductive Medicine Module 4a: Subfertility and Assisted Conception 4a: General Subfertility

IVF: PAST, PRESENT AND FUTURE

TECHNICAL GUIDANCE FOR THE ACCREDITATION OF ANDROLOGY LABORATORIES

COMMISSIONING POLICY FOR IN VITRO FERTILISATION (IVF)/ INTRACYTOPLASMIC SPERM INJECTION (ICSI) WITHIN TERTIARY INFERTILITY SERVICES V2.

WOMEN & INFANTS HOSPITAL Providence, RI CONSENT FOR IN VITRO FERTILIZATION USING A GESTATIONAL CARRIER (PATIENT/INTENDED PARENTS) 1.

Recommended Interim Policy Statement 150: Assisted Conception Services

Understanding IVF Processes in Surrogacy

SHIP8 Clinical Commissioning Groups Priorities Committee (Southampton, Hampshire, Isle of Wight and Portsmouth CCGs)

IVF AND PREIMPLANTATION GENETIC TESTING FOR ANEUPLOIDY (PGT-A) WHAT THE COMMUNITY PHYSICIAN NEEDS TO KNOW

Fertility treatment in trends and figures

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

Always placing innovation and excellence at the heart of our strategy, clinique ovo aims to meet your expectations and support your family project.

SPECIALIST FERTILITY SERVICES CLINICAL CRITERIA & CONTRACT AWARD

Synchronization between embryo development and endometrium is a contributing factor for rescue ICSI outcome

Fertility & Sterility Copyright 1999 American Society for Reproductive Medicine. Volume 72(4) October 1999 pp

Embryo Selection after IVF

Optimize your success

Unidad de Reproducción Centro Gutenberg

Journal of Assisted Reproduction and Genetics Plenum Publishing Corporation All Rights Reserved.

European IVF Monitoring (EIM) Year: 2012

August 2017 Changes. Reproductive Laboratory Checklist. CAP Accreditation Program

Advanced Assisted Reproductive Technologies

Placename CCG. Policies for the Commissioning of Healthcare. Policy for Assisted Conception Services

Transcription:

RBMOnline - Vol 7. No 6. 695-699 Reproductive BioMedicine Online; www.rbmonline.com/article/1008 on web 8 July 2003 Techniques Total quality improvement in the IVF laboratory: choosing indicators of quality Jacob Mayer obtained his Bachelor s and Master s degrees in Biology at Wright University in the USA. He continued his studies at The Johns Hopkins University where he obtained his PhD in Reproductive Physiology in 1980. He held a post-doctoral fellowship there from 1981 to 1982. He is currently Associate Professor and Reproductive Laboratories Director at the Jones Institute for Reproductive Medicine in Norfolk, Virginia, which is part of the East Virginia Medical School. He has published widely, is a member of numerous local and national committees and boards and has frequently presented papers at meetings. His particular interest is in quality management in the IVF laboratory. Dr Jacob Mayer Jacob F Mayer 1,3,, Estella Lynn Jones 1, Donna Dowling-Lacey 1, Fariba Nehchiri 2, Suheil J Muasher 2, William E Gibbons 1, Sergio C Oehninger 1 1 Department of Obstetrics and Gynecology, Jones Institute for Reproductive Medicine Eastern Virginia Medical School, 601 Colley Avenue, Norfolk, VA 23507, USA 2 Department of Obstetrics and Gynecology, Jones Institute for Reproductive Medicine, Northern Virginia/DC Center, 8501 Arlington Boulevard, Suite 500, Fairfax, VA 22031, USA 3 Correspondence: e-mail: mayerjf@evms.edu Abstract The purpose of this paper is to describe a programme of total quality improvement (TQI) within the IVF laboratory and to provide specific examples of indicators that could be used in such a TQI programme. Although TQI is sometimes confused with quality control (QC) and quality assurance (QA), there are major differences between the three quality plans: (i) QC is an activity designed to ensure that a specific element within the laboratory is functioning correctly; (ii) QA is a comprehensive programme designed to looks at a laboratory as a whole and to identify problems or errors that exist in an attempt to improve the entire process; (iii) TQI is also a comprehensive monitoring process designed not only to detect and eliminate problems, but also to enhance a laboratory s performance by exploring innovation and developing flexibility and effectiveness in all processes. Indicators used in a TQI plan should be objective, relevant to the laboratory, and measure a broad range of specific events or aspects of treatment that reflect the quality of care. for each of the indicators should be based on how the specific protocols used in the laboratory impact the outcomes and the nature of the indicators on quality of care. Keywords: assessment, improvement, indicators, IVF, laboratory, quality Introduction There is a common misconception that an embryology (IVF) laboratory s only responsibility is to perform clinical lab procedures. In fact, proper laboratory function requires the clinical IVF laboratory to engage in a cycle of activities beyond the realm of clinical assisted reproduction technology (ART) procedures. Some of these types of activities include consultation with the physician and clinical staff about the patient s treatment plan, ensuring that appropriate procedures are ordered, and proper identification of the patient/patient s specimens. In addition, there are a number of important activities that are continuous throughout the period of laboratory operation. Among these non-procedural function are a series of activities that are often confused (Rothmann, 1995): (i) Quality control (QC): these are activities designed to assure that a specific element within the laboratory is correct. An example of a common QC activity is documentation of refrigerator temperature on a daily chart. These measurements are compared to a range of acceptable limits that had been previously defined. This assures that one element of laboratory function, e.g. reagent storage, is being properly conducted. It should be noted that a QC programme treats each element that it monitors as an independent unit and does not attempt to measure the activities of the IVF laboratory as whole. (ii) Quality assurance (QA): quality assurance is a comprehensive programme for monitoring and evaluating an entire process. For an IVF laboratory, some common components of a QA programme would include: QC activities, a comprehensive written procedure manual, continuing educational activities, a programme for employee evaluation, a safety programme for the protection of both laboratory staff and patients, and the use of an external proficiency programme. QA programmes are designed to identify 695

696 problems or errors that exist in the laboratory and correct these defects. In this way, a QA programme looks at a laboratory as a whole and attempts to improve the entire process. (iii) Total quality improvement (TQI) is also a comprehensive monitoring process. However, TQI tries objectively to evaluate the quality of the IVF laboratory services provided to patients, employees, students, physicians, the parent institute, and the community. TQI does not seek simply to correct problems, nor is it a way to proactively eliminate errors. TQI also looks at ways to enhance a laboratory s performance by exploring innovation and developing flexibility and effectiveness in all processes. The purpose of this paper is to describe TQI within the IVF laboratory, and to provide some examples of IVF laboratory activities that could be monitored and evaluated as part of a TQI programme. TQI in the IVF laboratory The Joint Commission on Accreditation of Health Care Organizations (JCAHO) describes 10 steps for the development of a TQI programme for a healthcare organization (JCAHO, 1991): (i) Assign responsibility for overseeing the TQI plan In most cases, it will be the Laboratory Director who assumes overall responsibility for the laboratories TQI programme. (ii) Determine the scope of care for your facility The plan should identify all of the activities performed by your laboratory. This includes, but is not limited to, types of procedures, types of staff involved with these procedures, and when and where these services are provided. More specific examples of the kinds of questions that can be asked in order to determine the scope of care for an ART laboratory are: Does the laboratory perform IVF? GIFT? ZIFT? Does the laboratory offer use of donor spermatozoa in your treatment protocols? Does the laboratory treat single women or only married couples? Does the laboratory provide treatment every day of the week? The TQI plan should use the responses to these and other questions to develop a description of exactly what is the nature and extent of laboratory function. (iii) Identify important aspects of care List those important aspects of care and service that need to be monitored. Some aspects of care chosen for an IVF laboratory might include specimen collection, embryo culture, embryo assessment, transfer, and maintaining sterility. (iv) Identify indicators For each aspect of care identified in step iii, a few indicators of quality need to be chosen in order to monitor the related quality of care. Greater detail on this phase of TQI will be discussed in the following section. (v) Establish thresholds The threshold sets the critical level of quality laboratory performance for each indicator. Greater detail on this phase of TQI will also be discussed in the following section. (vi) Collect and organize the data The plan should indicate what data are to be collected. It should also specify how and by whom, the data will be collected. Decisions will need to be made also as to the nature of the data. Is it collected prospectively or retrospectively? Also, the samples size and frequency of collection will need to be established. (vii) Evaluate data After the data are collected, they need to be evaluated. (viii) Take action to improve care When an opportunity for improvement is recognized, an action plan is created and implemented to generate the improvement in patient care. The action plan represents an informed judgment about what needs to be changed to improve performance. (ix) Assess the effectiveness of the action plan Data continue to be collected and analysed to evaluate whether or not the action plan has really resulted in an improvement in patient care. (x) Documentation and reporting The conclusions, recommendations, actions and follow-up are all developed into a report and presented to the appropriate individuals. In an IVF setting, it is best to present the report to a TQI committee made-up of representatives from the entire ART team, physicians, nurses, laboratory staff, and administration. This preceding section was a quick summary of the elements necessary for the creation of a TQI programme. The remaining portion of this manuscript will concentrate on giving further details and suggestions for implementing step iv (identify indicators) and step v (establish thresholds) of a TQI plan for an IVF laboratory. Identify indicators within the IVF laboratory The indicators that are selected should have a number of specific characteristics. Indicators should be selected that are relevant to the aspects of care that have been identified for the IVF laboratory (see step iii). These indicators should also be related to the laboratory processes and outcomes. They should measure specific events or aspects of treatment that reflect the quality of care. It is also best if indicators are objective, since they are more easily measured and quantified. Often, it is helpful if the entire IVF team is asked to help identify and establish these indicators. Non-laboratory staff

from within the IVF team have a different perspective of patient care, and may be able to identify important indicators that may not be as evident from a laboratory viewpoint. A number of indicators have traditionally been used for IVF laboratories. Normal fertilization rates, polyspermic rates, embryo cleavage rates, intracytoplasmic sperm injection (ICSI) degeneration rates, implantation rates, pregnancy rates and thaw survival rates have been used as potential indicators of overall laboratory quality (Wiemer et al., 2001). True TQI involves more than an aggregate review of these indicators. If these same indicators are also monitored from other points of view, they can yield greater detail on the laboratory s performance and can help to indicate the type of corrective action needed to improve the quality of care. For instance, these same indicators could be used to assess the performance of individual laboratory staff, individual pieces of equipment, and specific supplies used in the in-vitro process. Technically demanding procedures such as ICSI are usually assessed through intra-laboratory comparisons of individual performance. Normal fertilization (2PN) rates, degeneration rates, implantation rates and pregnancy rates are all commonly used to determine if an individuals is able to perform the ICSI procedure at a technically acceptable level. Monitoring of individual performance usually results in the development of an action plan involving staff training or continuing education activities. Likewise, individual pieces of equipment can also be the target of performance assessment. For example, individual incubator chambers may be compared using such indicators as fertilization rates, cleavage rates or pregnancy rates. Action plans derived from reviews of equipment performance often suggest changes in equipment maintenance and replacement activities. Specific supplies used in the in-vitro process can be assessed using some of these same indicators. Different lots of media could be examined for changes in fertilization rates, cleavage rates, average embryo grade, average embryo cell number, or pregnancy. Such information may suggest that making changes in storage or shipping of supplies or even making a change in a vendor could improve quality. In addition to the clinical indicators that are most often measured in laboratories, other areas related to laboratory performance should also be incorporated. Safety indicators may include accident reports, incidents reports, specimen identification issues and patient infection rates. Indicators concerned with communication could involve clerical error rates on reports, timely dissemination of reports and mislabelling of specimens. Patient satisfaction indicators can be an important part of the effort to improve overall quality. Table 1 shows a few examples of the indicators an IVF laboratory may wish to use in its TQI plan. Clearly, a great number of other potential indicators could also be listed. Rather than try to use all possible indicators, a laboratory should decide on a manageable number of indicators that would be most critical to patient care. In other words, prioritize the indicators and select those most likely to yield useful information for improving laboratory performance. The indicator chosen for a laboratory s TQI plan should initially cover as broad a range of laboratory activities as possible. After the TQI programme is established, it will then be important to periodically modify the selected indicators. More promising indicators should replace elements of laboratory performance that do not yield useful information. Establish thresholds for selected indicators For each indicator incorporated into the laboratory s TQI programme, an appropriate threshold needs to be established. The threshold sets the critical level of quality laboratory performance for each indicator. Thresholds can be set in either positive or negative format. For example, the threshold for normal fertilization after ICSI could be expressed as: Normal fertilization after ICSI should be at least 60% (positive format); or less than 40% of ICSI oocytes should fail to fertilize normally (2PN two pronuclear) (negative format). Often, the form in which the threshold value is expressed is a function of how the data are being collected. Since clinical protocols are not uniform among IVF laboratories, the threshold values for many indicators may be different from laboratory to laboratory. This point can be illustrated with the following examination of different applications of cryopreservation protocols. Some IVF laboratories have established policies to only freeze high quality embryos. Since it has been shown that embryo quality can impact cryosurvival (Cohen et al., 1986), the threshold level for an indicator of embryo cryosurvival should be relative high in such an IVF programme. Other IVF laboratories have a different approach, and will freeze all nontransferred embryos regardless of quality. Because the overall quality of embryos being frozen is lower, the expectation for survival should also be set at a lower level. On the other hand, other indicators by their nature will have threshold values that will be common to all IVF laboratories. Indicators that measure extremely serious events will be universally set at very low levels. For example, the incidence of insemination with the wrong sperm sample, or the incidence of transferring embryos to the wrong patient will, by their nature, always have a threshold value of zero. Setting the proper threshold value for each indicator is a difficult but extremely critical task for a successful TQI programme. for each of the indicators need to be based on how the specific protocols used in the laboratory impact the outcomes and the nature of indicator s effect on quality of care. As illustrated in Table 2, thresholds that are set too high will erroneously indicate a problem with the laboratory performance. Conversely, a threshold set too low may fail to detect a laboratory deficiency or a poor level of performance. Finally, once a threshold is established, it is important to remember that it is not necessarily an absolute value. When a laboratory fails to meet its expected level of performance for a particular indicator, it is important to determine why the laboratory did not meet this expectation. Investigations may 697

Table 1. Examples of indicators of laboratory performance. Aspect of care Indicators Area of laboratory performance Oocyte collection % improper paper work; Communication % retrieval >36 h post-hcg Sperm collection % delayed collection; Communication % rejected semen specimen; % improper paperwork Gamete preparation % motile sperm yield; Technical skill or supply (enzyme) % oocyte degenerate post-stripping Specimen identification % mislabelled semen; Communication % mislabelled oocytes; % insemination mix-up; % thaw error; % transfer mix-up Fertilization % normal fertilization (2PN); Technical skill or equipment % abnormal fertilization; or supply (medium) or lab environment % normal fertilization ICSI; % degenerated post-icsi Cleavage % no cleavage; Equipment or supply (medium) % 4-cell 60 h post-insemination; or lab environment % 8-cell 60 h post-insemination; % blastocyst on day 5; % hatching blastocyst; average embryo grade; average number of cells Cryopreservation % patients with embryo freezing; Technical skill or equipment % survival post-thaw; or supply (medium) or lab environment % cleaved embryos 100% intact; % embryos that cleave post-thaw Embryo transfer % retained embryos in catheter; Technical skill or supply (medium) % transfers good quality embryos or lab environment Laboratory report Average time to final report; Communication Average no. clerical errors; Laboratory safety % lab staff injuries; Staff safety; patient safety % patients with infection postoocyte retrieval or transfer Outcomes % multiple pregnancies; Technical skill or equipment % ectopic; or supply (medium) or lab environment % spontaneous abortion Table 2. Impact of setting the threshold. Result 698 reveal an acceptable reason for a lower threshold value. For instance, an indicator like average embryo grade at transfer could fall below an establish threshold value if the patient population contains a higher than usual number of patients undergoing preimplantation genetic diagnosis (PGD). Since selection of embryos for transfer with a PGD procedure is based on genetic makeup and not necessarily on embryo grade, a drop in the average grade may not be indicating a problem with laboratory performance. It is important to understand that threshold values need to be constantly reviewed and adjusted to the appropriate settings. set too low Threshold value set too high appropriately set Failure to detect lab errors and correct poor performance Standards are impossible to achieve; improvement efforts are misdirected The laboratory has true view of its performance and can effectively direct its effort towards improvements

Targeted improvements Unlike QA, which simply seeks out problems/errors and corrects them, a TQI programme seeks to improve laboratory performance in all phases of laboratory activity, not just those indicating poor performance. In the programme at the Jones Institute, areas to be targeted for improvement are periodically identified. These targets are laboratory activities currently functioning at expected levels of performance, but which could significantly impact patient care if improved. This type of activity is philosophically different, since it attempts to proactively improved laboratory performance. QA programmes help laboratories live up to their potentials, while targeted improvements allow TQI to take a laboratory performance to a higher level. By way of illustration, some of the targeted improvements attempted at the Jones Institute over the last few years have included: application of the Spindle View system (LC Polscope, CRI Cambridge, MA, USA) to improve ICSI outcomes; improved embryo culture with the use of a low O 2 (5%) culture system; improved outcomes from freeze/thaw cycles with change in the timing of embryo thawing; and improvement in embryo culture with the use of intra-incubator air filters. Each of these ideas was suggested from the literature or from colleagues. They were incorporated into the laboratory in a controlled fashion for the purpose of improving a specific aspect of laboratory performance. In some cases, improved outcomes were achieved, while in others no improvement was detected. Conclusion The goal of a TQI programme is to improve patient care and satisfaction using a proactive strategy of ongoing evaluation and monitoring. Three key elements of TQI are: (i) understanding the situation; (ii) analysing data; and (iii) improving performance. Considerations and examples of how TQI initiatives may be introduced into an IVF laboratory have been provided. References Cohen J, Simons RS, Fehilly CB, Edwards RG 1986 Factors affecting survival and implantation of cryopreserved human embryos. Journal of In Vitro Fertilization and Embryo Transfer 3, 46 52. Joint Commission on Accreditation of Health Care Organizations 1991 Transitions From QA to QI. Using CQI approaches to monitor, evaluate and improve quality. Rothmann SA 1995 Developing a quality management program. In: Course X, Laboratory Management. Presented at the 28th Annual Postgraduate Program. American Society for Reproductive Medicine, Seattle, Washington, October 7, pp. 1 10. Wiemer KE, Anderson A, Weikert L 2001 Quality control in the IVF laboratory. In: Gardner DK, Weissman A, Howles CH, Shoham Z (eds) Textbook of Assisted Reproductive Techniques: Laboratory and Clinical Perspectives. Martin Dunitz, London, pp. 27 33. Paper based on contribution presented at the TWIN Meeting Alpha Andrology 2003 in Antwerp, Belgium, September 2003. Received 13 May 2003; refereed 28 May 2003; accepted 3 June 2003. 699